Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLVR System in Homogeneous or Upper Lobe Predominant Emphysema
NCT00630227Phase 2Completed
- Sponsor
- Aeris Therapeutics
- Start
- Feb 2008
- Primary completion
- Dec 2009
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of AeriSeal in emphysema, sponsored by Aeris Therapeutics. Started Feb 2008; status: completed.
02
Drugs
AeriSeal
03
Conditions
emphysema
Beyond the preview
Go deeper on NCT00630227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630227.